Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T17:32:32.047Z.
Calculation as of: 2026-10-06T17:32:32.047Z.
Quote observation: 2026-10-06T17:29:43.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 1773f2c5e671cf5ca9c154ebb177a5c9f9e5edbe4e379a4b832a158831e220bb
PEG RATIO
N/A
Jasper Therapeutics, Inc.
Market Cap
$8.99M
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Jasper Therapeutics, Inc. (JSPR) | $8.99M | N/A |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.29M | N/A |
| SeaStar Medical Holding Corporation (ICU)vs › | $9.37M | N/A |
| Ainos, Inc. (AIMD)vs › | $9.65M | N/A |
| DataMEDS AI, Inc. (MEDS)vs › | $8.53M | N/A |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.57M | N/A |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.36M | N/A |
| MetaVia Inc. (MTVA)vs › | $9.88M | N/A |
| HeartSciences Inc. (HSCS)vs › | $8.18M | N/A |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.10M | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
